S&P 500   3,385.82 (+1.51%)
DOW   27,965.01 (+1.87%)
QQQ   279.21 (+1.18%)
AAPL   116.24 (+1.88%)
MSFT   210.94 (+1.78%)
FB   264.16 (+0.91%)
GOOGL   1,474.63 (+0.59%)
AMZN   3,187.63 (+1.36%)
TSLA   429.14 (+2.40%)
NVDA   541.72 (+2.40%)
BABA   292.67 (+5.68%)
CGC   14.49 (-0.07%)
GE   6.29 (+2.78%)
MU   47.65 (-6.03%)
AMD   82.05 (+0.34%)
T   28.62 (+1.13%)
F   6.70 (+1.52%)
ACB   4.71 (+0.64%)
GILD   62.85 (+1.21%)
NFLX   500.14 (+1.35%)
DIS   124.90 (-0.40%)
BA   169.38 (+3.53%)
BAC   24.27 (+2.10%)
S&P 500   3,385.82 (+1.51%)
DOW   27,965.01 (+1.87%)
QQQ   279.21 (+1.18%)
AAPL   116.24 (+1.88%)
MSFT   210.94 (+1.78%)
FB   264.16 (+0.91%)
GOOGL   1,474.63 (+0.59%)
AMZN   3,187.63 (+1.36%)
TSLA   429.14 (+2.40%)
NVDA   541.72 (+2.40%)
BABA   292.67 (+5.68%)
CGC   14.49 (-0.07%)
GE   6.29 (+2.78%)
MU   47.65 (-6.03%)
AMD   82.05 (+0.34%)
T   28.62 (+1.13%)
F   6.70 (+1.52%)
ACB   4.71 (+0.64%)
GILD   62.85 (+1.21%)
NFLX   500.14 (+1.35%)
DIS   124.90 (-0.40%)
BA   169.38 (+3.53%)
BAC   24.27 (+2.10%)
S&P 500   3,385.82 (+1.51%)
DOW   27,965.01 (+1.87%)
QQQ   279.21 (+1.18%)
AAPL   116.24 (+1.88%)
MSFT   210.94 (+1.78%)
FB   264.16 (+0.91%)
GOOGL   1,474.63 (+0.59%)
AMZN   3,187.63 (+1.36%)
TSLA   429.14 (+2.40%)
NVDA   541.72 (+2.40%)
BABA   292.67 (+5.68%)
CGC   14.49 (-0.07%)
GE   6.29 (+2.78%)
MU   47.65 (-6.03%)
AMD   82.05 (+0.34%)
T   28.62 (+1.13%)
F   6.70 (+1.52%)
ACB   4.71 (+0.64%)
GILD   62.85 (+1.21%)
NFLX   500.14 (+1.35%)
DIS   124.90 (-0.40%)
BA   169.38 (+3.53%)
BAC   24.27 (+2.10%)
S&P 500   3,385.82 (+1.51%)
DOW   27,965.01 (+1.87%)
QQQ   279.21 (+1.18%)
AAPL   116.24 (+1.88%)
MSFT   210.94 (+1.78%)
FB   264.16 (+0.91%)
GOOGL   1,474.63 (+0.59%)
AMZN   3,187.63 (+1.36%)
TSLA   429.14 (+2.40%)
NVDA   541.72 (+2.40%)
BABA   292.67 (+5.68%)
CGC   14.49 (-0.07%)
GE   6.29 (+2.78%)
MU   47.65 (-6.03%)
AMD   82.05 (+0.34%)
T   28.62 (+1.13%)
F   6.70 (+1.52%)
ACB   4.71 (+0.64%)
GILD   62.85 (+1.21%)
NFLX   500.14 (+1.35%)
DIS   124.90 (-0.40%)
BA   169.38 (+3.53%)
BAC   24.27 (+2.10%)
Log in
NYSE:PFE

Pfizer Stock Forecast, Price & News

$36.85
+0.68 (+1.88 %)
(As of 09/30/2020 01:51 PM ET)
Add
Compare
Today's Range
$36.19
Now: $36.85
$36.85
50-Day Range
$35.65
MA: $37.19
$38.88
52-Week Range
$27.88
Now: $36.85
$40.97
Volume350,869 shs
Average Volume28.97 million shs
Market Capitalization$204.77 billion
P/E Ratio14.62
Dividend Yield4.18%
Beta0.67
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Merck KGaA; licensing agreement with BionTech AG; and collaboration agreements with Merck & Co., Inc. and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Read More
Pfizer logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.9Dividend Strength: 3.3Insider Behavior: 4.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.73 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP71708110
Phone212-733-2323

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$51.75 billion
Cash Flow$4.20 per share
Book Value$11.46 per share

Profitability

Net Income$16.27 billion

Miscellaneous

Employees88,300
Outstanding Shares5,556,880,000
Market Cap$204.77 billion
Next Earnings Date10/27/2020 (Confirmed)
OptionableOptionable
$36.85
+0.68 (+1.88 %)
(As of 09/30/2020 01:51 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PFE News and Ratings via Email

Sign-up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Pfizer (NYSE:PFE) Frequently Asked Questions

How has Pfizer's stock been impacted by COVID-19?

Pfizer's stock was trading at $32.17 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PFE stock has increased by 14.3% and is now trading at $36.76.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Pfizer?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 8 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Pfizer
.

When is Pfizer's next earnings date?

Pfizer is scheduled to release its next quarterly earnings announcement on Tuesday, October 27th 2020.
View our earnings forecast for Pfizer
.

How can I listen to Pfizer's earnings call?

Pfizer will be holding an earnings conference call on Tuesday, October 27th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Pfizer's earnings last quarter?

Pfizer Inc. (NYSE:PFE) issued its earnings results on Tuesday, July, 28th. The biopharmaceutical company reported $0.78 EPS for the quarter, topping the consensus estimate of $0.64 by $0.14. The biopharmaceutical company had revenue of $11.80 billion for the quarter, compared to analysts' expectations of $11.55 billion. Pfizer had a net margin of 28.80% and a return on equity of 25.11%. The company's revenue for the quarter was down 11.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.80 earnings per share.
View Pfizer's earnings history
.

How often does Pfizer pay dividends? What is the dividend yield for Pfizer?

Pfizer announced a quarterly dividend on Thursday, September 24th. Stockholders of record on Friday, November 6th will be given a dividend of $0.38 per share on Tuesday, December 1st. This represents a $1.52 annualized dividend and a dividend yield of 4.13%. The ex-dividend date is Thursday, November 5th.
View Pfizer's dividend history
.

How will Pfizer's stock buyback program work?

Pfizer announced that its board has approved a share buyback program on Friday, December 14th 2018, which permits the company to repurchase $10,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 3.8% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's leadership believes its stock is undervalued.

What guidance has Pfizer issued on next quarter's earnings?

Pfizer updated its FY20 earnings guidance on Tuesday, July, 28th. The company provided EPS guidance of $2.85-2.95 for the period, compared to the Thomson Reuters consensus estimate of $2.72. The company issued revenue guidance of $48.6-50.6 billion, compared to the consensus revenue estimate of $48.11 billion.

What price target have analysts set for PFE?

12 Wall Street analysts have issued 1 year price targets for Pfizer's stock. Their forecasts range from $24.00 to $53.00. On average, they anticipate Pfizer's share price to reach $39.44 in the next year. This suggests a possible upside of 7.3% from the stock's current price.
View analysts' price targets for Pfizer
.

Has Pfizer been receiving favorable news coverage?

Media coverage about PFE stock has been trending neutral this week, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Pfizer earned a daily sentiment score of 0.4 on InfoTrie's scale. They also gave news articles about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
View the latest news about Pfizer
.

Who are some of Pfizer's key competitors?

What other stocks do shareholders of Pfizer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pfizer investors own include AT&T (T), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Intel (INTC), Verizon Communications (VZ), AbbVie (ABBV), Walt Disney (DIS), Exxon Mobil (XOM), JPMorgan Chase & Co. (JPM) and NVIDIA (NVDA).

Who are Pfizer's key executives?

Pfizer's management team includes the following people:
  • Mr. Ian C. Read, Exec. Chairman (Age 65)
  • Mr. Albert Bourla D.V.M., DVM, Ph.D., CEO & Director (Age 57)
  • Mr. Frank A. D'Amelio, CFO & EVP of Global Supply & Bus. Operations (Age 61)
  • Dr. Mikael Dolsten, Chief Scientific Officer & Pres of Worldwide Research, Devel. and Medical (Age 60)
  • Mr. John D. Young, Group Pres & Chief Bus. Officer (Age 54)

What is Pfizer's stock symbol?

Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."

How do I buy shares of Pfizer?

Shares of PFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pfizer's stock price today?

One share of PFE stock can currently be purchased for approximately $36.76.

How big of a company is Pfizer?

Pfizer has a market capitalization of $204.27 billion and generates $51.75 billion in revenue each year. The biopharmaceutical company earns $16.27 billion in net income (profit) each year or $2.95 on an earnings per share basis. Pfizer employs 88,300 workers across the globe.

What is Pfizer's official website?

The official website for Pfizer is www.pfizer.com.

How can I contact Pfizer?

Pfizer's mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company can be reached via phone at 212-733-2323.

This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.